Jens Grueger is a Director and Partner at the Boston Consulting Group based in Zurich Switzerland. He provides expert advice to companies in the life science industries on pricing and market access. Since July 2019, he is an Affiliate Professor of Health Economics at the CHOICE Institute at the University of Washington School of Pharmacy in Seattle, USA. He is the 2020-2021 President of ISPOR, the leading professional society for health economics and outcomes research.
Prior to this, Jens had a distinguished career in the pharmaceutical industry. From 2011-2019, he was the Senior Vice President and Head of Global Access for F. Hoffmann-La Roche based in Basel, Switzerland. Under his leadership, Roche created rapid, broad and sustainable patient access for 12 new medicines and expanded access to essential cancer medicines in lower- and middle-income countries from 29 to 60%. Before this Jens was the Vice President and Head of Global Market Access Primary Care at Pfizer, based in New York and London (2009-2011), Head of Global Pricing & Health Economics at Novartis Pharma in Basel, Switzerland (1999-2009) and Director of Health Economics at the German affiliate of SmithKline Beecham Pharma in Munich (1994-1997). He founded Diversified Health Systems, a start-up company providing internet-based disease management services to physician networks in Europe (1997-1999).
Jens holds a MSc (Diplom) in Medical Statistics and Theoretical Medicine, and a PhD in Mathematical Statistics from the Technical University of Dortmund, Germany. He has authored more than 40 publications in biometrics, cancer epidemiology, and health economics.